Portal de investigação
The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis
Data de publicação:
Data Ahead of Print:
Autores da FMUP
Participantes de fora da FMUP
- Bousquet, J
- Toumi, M
- Anto, JM
- Bedbrook, A
- Czarlewski, W
- Valiulis, A
- Ansotegui, IJ
- Bosnic-Anticevich, S
- Brussino, L
- Canonica, W
- Cecchi, L
- Cherrez-Ojeda, I
- Chivato, T
- Costa, E.
- Cruz, AA
- Del Giacco, S
- Gemicioglu, B
- Haahtela, T
- Ivancevich, JC
- Jutel, M
- Kaidashev, I
- Klimek, L
- Kvedariene, V
- Kuna, P
- Larenas-Linnemann, DE
- Lipworth, B
- Morais-Almeida, M
- Mullol, J
- Papadopoulos, NG
- Patella, V
- Pham-Thi, N
- Regateiro, FS
- Rouadi, PW
- Samolinski, B
- Sheikh, A
- Taborda-Barata, L
- Ventura, MT
- Yorgancioglu, A
- Zidarn, M
- Zuberbier, T
Unidades de investigação
Abstract
Drug repurposing is a major field of value-added medicine. It involves investigating and evaluating existing drugs for new therapeutic purposes that address unmet healthcare needs. Several unmet needs in allergic rhinitis could be improved by drug repurposing. This could be game-changing for disease management. Current medications for allergic rhinitis are centered on continuous long-term treatment, and medication registration is based on randomized controlled trials carried out for a minimum of 14 days with adherence of 70% or greater. A new way of treating allergic rhinitis is to propose as-needed treatment depending on symptoms, rather than classical continuous treatment. This rostrum will discuss existing clinical trials on as-needed treatment for allergic rhinitis and real-world data obtained by the mobile health app MASK-air, which fo-cuses on digitally-enabled, patient-centered care pathways. (c) 2022 American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2022;10:2878-88)
Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Dados da publicação
- ISSN/ISSNe:
- 2213-2198, 2213-2201
- Tipo:
- Article
- Páginas:
- 2878-2888
- Link para outro recurso:
- www.scopus.com
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE Elsevier
Citações Recebidas na Web of Science: 5
Citações Recebidas na Scopus: 15
Documentos
- Não há documentos
Filiações
Keywords
- Value-added medicine; Repurposing; Allergic rhinitis; MASK-air; Treatment
Campos de estudo
Proyectos asociados
Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal (EPI-ASTHMA) - NCT05169619
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (EPI-ASTHMA) . AstraZeneca . 2021
Effect of a Mobile App on Improving Asthma Control in Adolescents and Adults With Persistent Asthma: A Pilot Randomized Multicentre, Superiority Clinical Trial (mINSPIRERS) - NCT05129527
Investigador Principal: João de Almeida Lopes da Fonseca
Ensaio Clínico Académico (mINSPIRERS) . 2021
Utilização em estudos observacionais do Registo de Asma Grave Portugal.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Observacional Académico (RAG) . 2020
Clinical Research Collaboration Severe Heterogenous Asthma Research collaboration, Patient-centered (CRC SHARP).
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (SHARP) . European Respiratory Society . 2021
Seroprevalence of SARS-CoV-2 and assessment of epidemiologic determinants in Portuguese municipal workers
Investigador Principal: Bernardo Manuel De Sousa Pinto
Estudo Clínico Académico (SARS-CoV-2) . 2021
Efficiency in Spine Care ? Assessing outcomes and costs to inform healthcare improvement
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2022
Use of secondary data, health technology assessment methods and economic modelling applied to penicillin allergy
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Using different data sources for the identification of asthma patients and those at high risk of adverse outcomes
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Phenotypes of Chronic Diseases of the Airways: Towards Multidimensional Data -Driven Profiling
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Citar a publicação
Bousquet J,Toumi M,Sousa B,Anto JM,Bedbrook A,Czarlewski W,Valiulis A,Ansotegui IJ,Bosnic S,Brussino L,Canonica W,Cecchi L,Cherrez I,Chivato T,Costa E,Cruz AA,Del Giacco S,Fonseca J,Gemicioglu B,Haahtela T,Ivancevich JC,Jutel M,Kaidashev I,Klimek L,Kvedariene V,Kuna P,Larenas DE,Lipworth B,Morais M,Mullol J,Papadopoulos NG,Patella V,Pham N,Regateiro FS,Rouadi PW,Samolinski B,Sheikh A,Taborda L,Ventura MT,Yorgancioglu A,Zidarn M,Zuberbier T. The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis. J. Allergy Clin. Immunol. Pract. 2022. 10. (11):p. 2878-2888. IF:9,400. (1).
